Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
The Healthcare Information and Management Systems Society (HIMSS) has officially canceled its 2020 annual meeting in Orlando, Florida, due to continued concerns over the new coronavirus.
AI technology could play a vital rule in the diagnosis and treatment of aggressive posterior retinopathy of prematurity (AP-ROP) in infants, according to new research published in Ophthalmology.
SymphonyAI Group, a private group of companies specializing in AI, announced Wednesday, March 4, that it has acquired TeraRecon. No financial details have been shared at this time.
Augmented reality (AR) technology could play a pivotal role in the interventional radiology (IR) suite of the future, according to a new study published in the Journal of Vascular and Interventional Radiology.
Proscia, a Philadelphia-based AI technology company, has partnered with the University of California, San Francisco (UCSF) to improve cancer diagnoses and patient outcomes.
